✦ LIBER ✦

196 Possible problems with clinical selection criteria used in Alzheimer's Disease clinical trials

✍ Scribed by J. Wilimer; E. Mohr

Book ID: 118577916
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 147 KB
Volume: 17
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(96)80198-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of CSF biomarkers in Alzheimer’s dis

Use of CSF biomarkers in Alzheimer’s disease clinical trials

✍ K. Blennow; H. Zetterberg 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 57 KB

Adapting scales for use in global clinic

Adapting scales for use in global clinical Alzheimer's disease trials

✍ Morihiro Sugishita 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

30 Problems in performing clinical trial

30 Problems in performing clinical trials in Alzheimer's disease (AD) and vascular dementia (VaD)

✍ B. Kittner; M. Rother; M. Rößner; K.-H. Labs; F.J. Huff 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Problems Arising from the Generalising o

Problems Arising from the Generalising of Treatment Efficacy from Clinical Trials in Alzheimer’s Disease

✍ Dr Robert Becker, Stephen Markwell 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 175 KB

Depression in Alzheimer's disease: speci

Depression in Alzheimer's disease: specificity of depressive symptoms using three different clinical criteria

✍ Knut Engedal; Maria Lage Barca; Jerson Laks; Geir Selbaek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Previous studies report contradictory results on whether the symptoms of depression in Alzheimer's disease patients are the same as in cognitively normal persons. Thus, provisional criteria for depression in Alzheimer's disease (PDC-dAD) have been developed. Aim : To examine which symptoms in AD pat

S.25.02 Results from clinical trials wit

S.25.02 Results from clinical trials with monoclonal antibodies in Alzheimer's disease

✍ N.D. Prins 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB